General Western Blot Reagents
Abcam BRD-7389, p90 ribosomal S6 kinase RSK inhibitor, 5MG
MW 366.4 Da. p90 ribosomal S6 kinase RSK inhibitor (IC₅₀ values are 1.2, 1.5 and 2.4 μM for RSK3, RSK1 and RSK2 respectively). Upregulates insulin expression in pancreatic α-cells. Shows reprogramming effects in terminally differentiated cells.
The product is subject to the following: Abcam Restricted Use Statement
Abcam n-Octyl-beta-D-maltopyranoside, non-ionic detergent, 1G
MW 454.4 g/mol, Purity >98%. Water soluble non-ionic detergent suitable for solubilization and isolation of membrane proteins.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human c-Myc peptide, 1MG
Human c-Myc peptide is a Synthetic blocking peptide. Suitable for BL.
Protein/ Peptide/ Enzyme Synonyms: BHLHE39, MYC, Myc proto-oncogene protein, Class E basic helix-loop-helix protein 39, Proto-oncogene c-Myc, Transcription factor p64, bHLHe39
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Sigma Aldrich Fine Chemicals Biosciences PVDf Western Blotting Memb
PVDf Western Blotting Membranes are hydrophobic microporous polyvinylidene difluoride (PVDf) membranes with a pore size of 0.2mum. The PVDf Western Blotting Membranes are ideal for western and dot blots. The high binding capacity high mechanical strength and chemical resistance of the PVDf membrane makes it specifically useful for protein blotting. The combination of strong sample retention and low background binding generates excellent signal-to-noise ratios in colorimetric and chemiluminescent detection. The primary binding mechanism includes electrostatic and hydrophobic nature. Adsorption Goat IgG 294mug/cm2 BSA 131mug/cm2 insulin 85mug/cm2
Abcam SB 334867, O x 1 receptor antagonist, 1MG
MW 319.32 Da, Purity >99%. Selective OX1 receptor antagonist. Inhibits orexin-A induced intracellular calcium release (IC50 = 226 nM). Shows anxiolytic, sedative and anorectic effects *in vivo.*.
The product is subject to the following: Abcam Restricted Use Statement
Abcam BMS 345541, IKK-2 and IKK-1 inhibitor, 50MG
MW 255.32 Da, Purity >98%. Highly selective cell permeable IKK-2 and IKK-1 inhibitor (IC₅₀ values are 0.3 and 4 μM for IKK-2 and IKK-1 respectively). Blocks NF-κB-dependent transcription. Shows anti-inflammatory and radiosensitizing effects in vivo. Orally active.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Q x -314 bromide (N-Ethyllidocaine bromide), Na+ channel blocker, 250MG
MW 343.3 Da, Purity >99%. A membrane impermeable quaternary lidocaine derivative. Blocks voltage-sensitive Na+ conductance when applied intracellularly. Soluble in 1 ml water to give specified mM/ml concentration.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Rhod-2 AM, fluorescent Ca2+ indicator, 1MG
Rhod-2 AM, a fluorescent Ca2+ indicator is cell-permeable. Binds to Ca2+ (Kd = 570 nM) and fluoresces yellow/orange upon Ca2+ binding. - Cited in over 20 publications - Purity > 93% - Soluble in DMSO to 1 mg/ml - Excitation/Emission: Ex: 552nm, Em: 581nm
The product is subject to the following: Abcam Restricted Use Statement
Abcam Triacsin C, acyl-CoA synthetase inhibitor, 100UG
MW 207.27 Da, Purity >90%. Potent, specific acyl-CoA synthetase inhibitor (Ki values are 15 nM and 2 μM for Faa2p and Faa4p respectively). Inhibits synthesis of cholesteryl ester and triacylglycerol in vitro. Vasodilator agent. Orally active. Active in vivo and in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam TPCA 1, IkappaB kinase inhibitor, 10MG
MW 279.29 Da, Purity >98%. Potent, selective IκB kinase inhibitor (IC₅₀ = 17.9 nM). Inhibits NF-κB nuclear localization. Shows anti-inflammatory effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam Do x ycycline hyclate, matri x metalloprotease inhibitor, 25G
MW 1025.9 Da, Purity >97%. Synthetic tetracycline; matrix metalloprotease (MMP) inhibitor. Inhibits tumour growth, suppresses cell proliferation and induces apoptosis in vitro and in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Z-YVAD-FMK, Irreversible caspase-1 inhibitor, 1MG
MW 630.7 Da, Purity >98%. Z-YVAD-FMK, Irreversible caspase-1 inhibitor. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam B-Phycoerythrin Conjugation Kit - Lightning-Link, 600UG
Labeling in < 4 hrs with 30 secs hands-on time using B-Phycoerythrin Conjugation Kit - Lightning-Link ab102871. 100% antibody recovery.
The product is subject to the following: Abcam Restricted Use Statement
Abcam APC/Cy5.5 Conjugation Kit - Lightning-Link, 3 x 10UG
Labeling in < 4 hrs with 30 secs hands-on time using APC/Cy5.5 Conjugation Kit - Lightning-Link ab102855. 100% antibody recovery.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Do x orubicin hydrochloride, Topoisomerase II inhibitor, 50MG
MW 580 Da, Purity >98%. Topoisomerase II inhibitor (IC₅₀ = 100 nM, Hep3B cells). DNA intercalator that prevents synthesis of nucleic acid. Induces apoptosis.
The product is subject to the following: Abcam Restricted Use Statement